At close: 4:00:01 PM EST
After hours: 4:00:11 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 12, 2024 | -- |
| COHEN FREDERICK E. M.D. PH.D. Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 12, 2024 | -- |
| GILEAD SCIENCES INC Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 12, 2024 | 4,126,120 |
| JONES RYAN ALEXANDER Chief Financial Officer | Conversion of Exercise of derivative security | May 28, 2024 | 43,950 |
| NORTHPOND VENTURES III GP, L.L.C. Former | Purchase | Feb 12, 2024 | -- |
| SEIDENBERG BETH C Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 12, 2024 | -- |
| VIDA VENTURES, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 12, 2024 | -- |
| WALKER KAREN MARIE Chief Technology Officer | Conversion of Exercise of derivative security | Jun 6, 2024 | 9,636 |
| WESTLAKE BIOPARTNERS FUND I, L.P. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 12, 2024 | -- |
Related Tickers
ANRO Alto Neuroscience, Inc.
4.3600
-1.13%
KYMR Kymera Therapeutics, Inc.
38.17
-5.80%
IPSC Century Therapeutics, Inc.
0.9900
-7.48%
ACLX Arcellx, Inc.
69.08
-4.40%
LYEL Lyell Immunopharma, Inc.
0.6040
-7.32%
MGX Metagenomi, Inc.
3.1300
+1.29%
CRNX Crinetics Pharmaceuticals, Inc.
40.59
-16.31%
ALXO ALX Oncology Holdings Inc.
1.7700
-4.32%
MLTX MoonLake Immunotherapeutics
46.32
-3.85%
CGEM Cullinan Therapeutics, Inc.
11.19
+0.54%